stockrow
Friday 6 November 2026
Export GRAL’s income statement to Excel — free account
GRAIL, Inc.
GRAL Healthcare Diagnostics & Research
GRAIL, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $147.2 million, up 17.2% from fiscal 2024.
- Revenue
- +3.71%
- EPS
- +10.2%
- Free cash flow
- −24.9%
Quarter to September 2026, against a year earlier
125.09
5.96
+5.00%
Follow GRAL
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
— | 6 | — | — |
+8 more TTM periods Free account |
| (17.31%) | (16.12%) | (16.09%) | (16.07%) | ||
| (15.24%) | (14.12%) | (13.99%) | (13.83%) | ||
ROIC |
(14.74%) | (20.79%) | (20.28%) | (21.00%) | |
Return on Tangible Assets |
(51.34%) | (44.73%) | (46.48%) | (44.10%) | |
Average Days of Receivables |
41.62 | 43.64 | 47.57 | 45.37 | |
Free Cash Flow per Share |
(6.67) | (6.87) | (7.19) | (8.16) | |
Free Cash Flow |
(312.00) | (296.16) | (292.33) | (299.92) | |
Capital Expenditures |
(5.76) | (1.41) | (1.35) | (0.91) | |
| Other line items | |||||
Cash ROIC |
(12.72%) | (8.70%) | (8.80%) | (8.61%) | |
Accounts Receivable Turnover |
9.44 | 9.16 | 7.87 | 7.62 | |
Accounts Payable Turnover |
0.00 | 32.09 | 40.83 | 60.56 | |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 12.18 | 8.00 | 3.62 | |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.26) | (0.26) | (0.23) | (0.24) | |
Research and Development Expense of Revenue |
111.89% | 115.57% | 121.82% | 133.04% | |
Selling, General and Administrative Expense of Revenue |
186.44% | 176.14% | 172.42% | 187.40% | |
Share Based Compensation of Revenue |
38.55% | 38.88% | 37.70% | 39.60% | |
Operating CF/Net income |
0.75 | 0.75 | 0.74 | 0.73 | |
Depreciation/Fixed assets |
0.00 | 3.58 | 3.39 | 3.15 | |
Capex/Depreciation |
0.00 | (0.01) | (0.01) | (0.01) | |
Revenue per Share |
3.56 | 3.83 | 3.84 | 4.00 | |
Operating CF per Share |
(6.55) | (6.84) | (7.16) | (8.14) | |
Capex per Share |
(0.12) | (0.03) | (0.03) | (0.02) | |
Capex to Sales |
0.03 | 0.01 | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 5 Nov 2026